Total investments 22
Average round size 
$70M
The average size of a deal this fund participated in
Portfolio companies 18
Rounds per year 3.14
Lead investments 2
Follow on index
0.18How often the fund supports its portfolio startups at next rounds
Exits 9
Key employees Soon
New York, New York, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Acorn Bioventures:
Typical Co-investors
Acorn Bioventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Acorn Bioventures:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| 1818 Venture Capital | Guernsey, Guernsey, NA - Guernsey |
| Acuity Brands | Atlanta, Georgia, United States |
| AI Fund | California, Palo Alto, United States |
| Ascend Capital Partners | - |
| Autobot Capital Partners | Beijing, Beijing, China |
| Bellwether | - |
| Chariot Gold Limited | - |
| Checketts Partners Investment Fund | - |
| Cheval Holdings | - |
| Clear Future | Herzliya, Israel, Tel Aviv |
| Commodore Capital | New York, New York, United States |
| GeneScience Pharmaceuticals | - |
| Hermann Companies | Arkansas, Paragould, United States |
| HumanCo | New York, New York, United States |
| Koch Equity Development | Kansas, United States, Wichita |
| Moneta VC | Israel, Ramat Gan, Tel Aviv |
| National Building and Marketing | Ar Riyad, Riyadh, Saudi Arabia |
| Orgain | California, Irvine, United States |
| Technologies SAS | - |
| Yiguo Group | Changning, China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Neurosterix | $63M | 03 Apr 2024 | Geneve, Geneva, Switzerland | ||
OnKure | $54M | 23 May 2023 | Boulder, Colorado, United States | ||
Neuron23 | $100M | 30 Mar 2022 | San Francisco, California, United States | ||
ONK Therapeutics | $21M | 06 Jan 2022 | Galway City, County Galway, Ireland | ||
Eliem Therapeutics | $60M | 24 May 2021 | Washington, United States | ||
OnKure | $56M | 04 Mar 2021 | Boulder, Colorado, United States | ||
| $80M | 16 Dec 2020 | San Francisco, California, United States | |||
Freeline | $80M | 30 Jun 2020 | England |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Acorn Bioventures?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 22
Average round size 70M
Rounds per year 3.14
Peak activity year 2024
Lead investments 2
Follow on index 0.18
Exits 9
Group Appearance index 1.00
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Neurosterix | $63M | 03 Apr 2024 | Geneve, Geneva, Switzerland | ||
OnKure | $54M | 23 May 2023 | Boulder, Colorado, United States | ||
Neuron23 | $100M | 30 Mar 2022 | San Francisco, California, United States | ||
ONK Therapeutics | $21M | 06 Jan 2022 | Galway City, County Galway, Ireland | ||
Eliem Therapeutics | $60M | 24 May 2021 | Washington, United States | ||
OnKure | $56M | 04 Mar 2021 | Boulder, Colorado, United States | ||
| $80M | 16 Dec 2020 | San Francisco, California, United States | |||
Freeline | $80M | 30 Jun 2020 | England |
